Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Affymetrix and Singapore-based Start-up PathGEN Dx Sign Partnership

Published: Monday, August 27, 2012
Last Updated: Sunday, August 26, 2012
Bookmark and Share
Agreement for diagnostic test development for pathogen detection.

Affymetrix, Inc. and PathGEN Dx Pte. Ltd. have announced that they have signed a Powered by Affymetrix™ (PbA) Program agreement.

Under this PbA agreement, PathGEN Dx will develop an in-vitro diagnostic kit for comprehensive pathogen detection using their PathGEN® PathChip and is based on a patented, efficient, and accurate microarray-based protocol and analysis method.

The kit will be comprised of PathGEN Dx’s proprietary reagents, an automated software package, and a contract manufactured GeneChip® microarray from Affymetrix.

It will detect the presence of more than 70,000 viral and bacterial genomes from a wide variety of human samples, annotate the genomic information, and identify co-infecting pathogens.

Dr. Martin Hibberd, PathGEN Dx Co-Founder, said, “This will be the start of our development plan for a diagnostic microarray that we feel will ultimately help medical researchers and surveillance investigators identify the full range of viruses and bacteria in their samples.”

“We are very pleased to have PathGEN Dx join the Affymetrix’ PbA Program. This adds significantly to our PbA Program in which we help partners to develop novel molecular diagnostic tests that will potentially provide solutions for directing proper treatment for patients,” said Roger Schaller, Sr. Director of Global Business Development for Clinical Applications at Affymetrix.

“We are very proud that PathGEN Dx, the first spin-off from GIS, has achieved this collaboration that will significantly advance their reach to the clinical diagnostics global market. The journey first began in 2004 as a project in GIS, and then funded by Exploit Technologies in 2008 to clinically validate, productize, and develop the business strategy. This is an exciting next phase in PathGEN DX’s entrepreneurial journey and we look forward to greater success,” said Mr. Philip Lim, CEO of Exploit Technologies, A*STAR’s technology transfer arm.

“The Genome Institute of Singapore is pleased to support PathGEN Dx and look forward to incubating more startups in the future,” said Prof. Ng Huck Hui, Acting Executive Director of GIS.

This PbA Program agreement also provides PathGEN Dx access to Affymetrix’ international distribution network.

Dr. Christopher Wong, Founder of PathGEN Dx, added “We are pleased to join the ranks of other PbA Program partners, such as Roche Diagnostics and Pathwork Diagnostics in adopting the Affymetrix technology in our IVD product development program.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Affymetrix Releases Data from Validated SNP Database for Design of Custom Genotyping Arrays
Validated SNPs from 1000 genomes project and custom Axiom arrays will enable the next wave of genotyping studies.
Tuesday, July 27, 2010
Affymetrix Delivers First Custom Axiom Array for Kaiser Permanente/UCSF Genotyping Project
6,000-sample pilot studies completed on Axiom catalog array with superior performance.
Tuesday, May 11, 2010
Affymetrix and Beckman Coulter Join Forces to Provide Automated Target Preparation Solutions
The collaboration will provide scientists with optimized, robust solutions for genomic research, fortified by end-to-end support.
Wednesday, September 02, 2009
Affymetrix and Beckman Coulter Join Forces to Provide Automated Target Preparation Solutions
The collaboration will provide scientists with optimized solutions for genomic research, fortified by end-to-end support.
Thursday, August 27, 2009
ServiceXS Acquires GeneTitan™ Instrument from Affymetrix
GeneTitan™ combines the hybridization oven, fluidics processing and imaging device to automate the microarray experiments.
Friday, July 03, 2009
Affymetrix to Acquire Panomics
The assay products for low to mid-plex applications will strengthen company's position in high-growth validation and routine-testing markets.
Wednesday, November 12, 2008
South African Core Lab Adopts Affymetrix Technology for Genomic Studies
The Centre for Proteomic and Genomic Research is using many Affymetrix GeneChip arrays to explore applications with molecular diagnostics.
Wednesday, October 08, 2008
Korea NIH Expands KARE Project with Second Affymetrix Technology Order
Institute purchases Affymetrix SNP Array 6.0 to validate previous findings and identify new genetic variations across additional 13,000 samples.
Tuesday, May 27, 2008
LineaGen Selects Affymetrix Technology to Discover Genes Associated With Autism and Multiple Sclerosis
Collaboration of scientists from the University of Utah and Vanderbilt University looks to gain insights for the diagnosis of multiple sclerosis (ms) and autism.
Tuesday, May 13, 2008
Affymetrix Extends Collaborations in Cancer Research Program to North America
More than 25 participants use Affymetrix’ integrated genomics solution to accelerate research on more than 10 types of cancer, according to company.
Wednesday, April 16, 2008
Affymetrix Signs Agreement with Avesthagen Limited
The AVESTAGENOME Project™ to study genetic basis of longevity and create genetic, genealogical and medical database of the Parsi community.
Tuesday, March 25, 2008
Affymetrix Launches Microarray Data Analysis Training University
Affymetrix to launch Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America.
Thursday, October 18, 2007
The Wellcome Trust Case Control and Cardiogenics Consortiums Identify key Genes in Coronary Artery Disease with Affymetrix Technology
Team discovers genetic variant that may increase the risk of developing CAD by as much as 36 percent.
Friday, July 20, 2007
Genetic Association Information Network Selects Affymetrix SNP Array 6.0 for Genetic Studies
GAIN will use the Genome-Wide Human SNP Array 6.0 for a series of studies designed to identify the genetic causes of common, complex diseases.
Tuesday, July 03, 2007
German Genomics Research Project to Analyze DNA Samples Using Affymetrix Technology
National Genome Research Network has purchased Affymetrix’s Genome-Wide Human SNP Array 5.0 to genotype 17,000 individuals in a study of 25 diseases.
Friday, April 27, 2007
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Device May Detect Urinary Tract Infections Faster
A Lab-on-a-Disc platform developed by a German and Irish team of researchers dramatically cut the time to detect bacterial species that cause urinary tract infections -- a major cause of sepsis.
Automation Abound at AACC in Atlanta
Discover the latest breakthroughs, trends and products from the AACC Annual Meeting & Clinical Lab Expo.
Real-Time Data for Cancer Therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!